Svennerholm A M, Jertborn M, Gothefors L, Karim A M, Sack D A, Holmgren J
J Infect Dis. 1984 Jun;149(6):884-93. doi: 10.1093/infdis/149.6.884.
Mucosal and systemic immune responses to a new oral cholera vaccine, consisting of the B subunit plus killed vibrios, were studied in Bangladeshi volunteers and compared with those to clinical cholera. A single peroral dose of vaccine induced a local IgA antitoxin response in intestinal-lavage fluid of seven of eight vaccinees; the response closely mimicked that of patients convalescing from cholera, and evidence of the induction of local immunologic memory was found as well. Two peroral doses were needed for stimulation of an intestinal IgA immune response to the lipopolysaccharide of Vibrio cholerae that was comparable to the response obtained after clinical cholera. This response to peroral immunization was considerably stronger than that to parenteral vaccination, although the intramuscular route gave rise to the strongest IgG antitoxin and antilipolysaccharide responses in serum. The results suggest that B subunit-whole cell vaccine, when given in at least two oral doses, may be a good candidate for use in cholera prophylaxis.
在孟加拉国志愿者中研究了对一种由B亚单位加灭活弧菌组成的新型口服霍乱疫苗的黏膜和全身免疫反应,并与临床霍乱的免疫反应进行了比较。单剂量口服疫苗在8名接种者中的7人的肠道灌洗液中诱导了局部IgA抗毒素反应;该反应与霍乱康复患者的反应非常相似,并且还发现了局部免疫记忆诱导的证据。需要两剂口服疫苗才能刺激对霍乱弧菌脂多糖的肠道IgA免疫反应,该反应与临床霍乱后获得的反应相当。尽管肌内途径在血清中产生最强的IgG抗毒素和抗脂多糖反应,但口服免疫的这种反应比注射疫苗的反应要强得多。结果表明,至少口服两剂的B亚单位全细胞疫苗可能是霍乱预防的良好候选疫苗。